Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001069899

PAHC

PHIBRO ANIMAL HEALTH CORP
$37.38 ▲ +4.22%
Prev close $35.87
Market cap$1.5B
12-mo target$44.00 (+17.7%)
15 New Institutional Positions15 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on PAHC right now — valuation, ownership and activity at a glance.
Market Cap
$1.5B
Cap Size
Small Cap
Inst. Holders
50 funds
Inst. Value
$508.8M
Inst. Activity
15 buys / 15 sells
Insider Activity
$317.7K buy / $5.3M sell
Insider Net $
-$5.0M
SEC Reports
6
Price chart 30d -6.4%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 26, 2026 earnings_calendar
PAHC Q4 2026 Earnings After Market Close — 2026-08-26
Aug 6, 2026 Insider
David Glenn was granted 3,482 shares
Chief Financial Officer
Aug 6, 2026 Insider
Miller Larry Lee was granted 3,726 shares
Chief Operating Officer
Aug 6, 2026 Insider
Bendheim Daniel M was granted 11,699 shares
President and CEO
Jul 28, 2026 SEC
Phibro Animal Health Corporation declared a quarterly cash dividend of $0.12 per share on its Class A and Class B common
8-K — Impact 2/10
Jun 30, 2026 Inst.
FMR LLC — ADD
3,160,281 shares ($99.2M)
Jun 30, 2026 Inst.
MILLENNIUM MANAGEMENT LLC — DOUBLED
936,701 shares ($29.4M)
Jun 26, 2026 SEC
Phibro Animal Health appointed Daniel (Dani) Bendheim as CEO and President effective July 1, 2026, with an employment ag
8-K — Impact 2/10
Analyst ratings buy % -9.1%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
DateFirmActionRatingFirm rating
May 14, 2026CitigroupMAINTAINNeutral 55%
Apr 15, 2026CitigroupINITIATENeutral 55%
Monthly consensus history
PeriodStr. BuyBuyHoldSellStr. SellBuy %Distribution
Sep 1, 20260152210%
Aug 1, 20260152210%
Jul 1, 20260152210%
Jun 1, 20260152210%
May 1, 20260152210%
Apr 1, 20260142211%
Mar 1, 20260142211%
Feb 1, 20260142211%
Price targets
Where 4 covering analysts think PAHC trades over the next 12 months.
$44.00 +17.7% upside Buy
Current$37.39 Low$35.00 Median$43.00 High$55.00 4 analysts
$35.00$55.00
Analyst rating Hold· 3.0/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
6 SEC filing reports analyzed · 1 bullish, 1 bearish, 0 mixed, 4 neutral · avg impact 3.5/10.
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Aug 26, 2026
earnings_calendar
PAHC Q4 2026 Earnings After Market Close — 2026-08-26
Jul 15, 2026
ftd
FTD: PAHC — 20,960 shares ($0.7M) failed to deliver
Settlement: 20260715, Price: $33.04, FTD Value: $692,518.4, PHIBRO ANIMAL HEALTH CORPORATI
Jul 14, 2026
ftd
FTD: PAHC — 17,766 shares ($0.6M) failed to deliver
Settlement: 20260714, Price: $33.00, FTD Value: $586,278, PHIBRO ANIMAL HEALTH CORPORATI
May 7, 2026
short_volume
Short Volume: PAHC — 65.2% short (0.5M / 0.7M)
Short: 456,268 | Exempt: 12,807 | TRF Vol: 700,281 | Short Ratio: 65.2% | Off-exchange volume (dark pool + OTC)
May 6, 2026
earnings_calendar
PAHC Q3 2026 Earnings Scheduled — 2026-05-06
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
PeriodEPS Est.RangeGrowth30d RevUp/DnRevenue#
Current Q$0.76$0.75–$0.784.6%-3.4%0↑ 1↓$0.4B3
Next Q$0.99$0.97–$1.0113.8%+8.8%1↑ 0↓$0.4B2
Current FY$3.50$3.48–$3.538.7%+5.5%5↑ 0↓$1.6B4
Next FY$3.84$3.68–$4.049.8%+5.7%4↑ 0↓$1.6B4
Current-quarter EPS estimate — revision history
WhenEPS estimateChange vs now
Current$0.763—
7d ago$0.767-0.004
30d ago$0.790-0.027
60d ago$0.790-0.027
90d ago$0.790-0.027
Institutional ownership
Which big funds own PAHC (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $508.8M total value (16,182,582 shares) as of 2026-Q2. Top holders: BlackRock,, FMR, STATE.
Top holders — 2026-Q2
FundSharesValue% TrackedLast move
BlackRock, Inc.3,219,040$101.1M19.9%—
FMR LLC3,160,281$99.2M19.5%ADD +45.4%
STATE STREET CORP1,038,382$32.6M6.4%—
MILLENNIUM MANAGEMENT LLC936,701$29.4M5.8%DOUBLED +1578.1%
VANGUARD CAPITAL MANAGEMENT LLC923,318$29.0M5.7%—
GEODE CAPITAL MANAGEMENT, LLC657,350$20.6M4.1%—
DIMENSIONAL FUND ADVISORS LP531,087$16.7M3.3%—
VANGUARD PORTFOLIO MANAGEMENT LLC508,486$16.0M3.1%—
RENAISSANCE TECHNOLOGIES LLC480,500$15.1M3.0%—
MORGAN STANLEY412,634$13.0M2.5%—
Recent position changes
FundActionPrevCurrentChangeValue
FMR LLCADD2,173,1263,160,281+45.4%$99.2M
MILLENNIUM MANAGEMENT LLCDOUBLED55,819936,701+1578.1%$29.4M
Nuveen, LLCTRIM455,891314,079-31.1%$9.9M
LPL Financial LLCTRIM129,15767,586-47.7%$2.1M
LOS ANGELES CAPITAL MANAGEMENT LLCTRIM92,06767,083-27.1%$2.1M
BANK OF AMERICA CORP /DE/TRIM78,95748,947-38.0%$1.5M
ALLIANCEBERNSTEIN L.P.TRIM72,68223,720-67.4%$1.3M
SEI INVESTMENTS CONEAR_EXIT156,94836,686-76.6%$1.2M
JACOBS LEVY EQUITY MANAGEMENT, INCTRIM114,01833,024-71.0%$1.0M
AMERICAN CENTURY COMPANIES INCDOUBLED12,28231,737+158.4%$996.5K
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
9 insiders, 50 transactions. Net -$5.0M — $317.7K bought, $5.3M sold.
DateInsiderTitleTypeSharesPriceValue
Aug 6, 2026David GlennChief Financial OfficerAWARD3,482——
Aug 6, 2026Miller Larry LeeChief Operating OfficerAWARD3,726——
Aug 6, 2026Bendheim Daniel MPresident and CEOAWARD11,699——
Aug 6, 2026BENDHEIM JACKExecutive ChairmanAWARD12,103——
Aug 6, 2026Miller Larry LeeChief Operating OfficerAWARD3,522——
Aug 6, 2026Escudero Lisa AnnSee RemarksAWARD1,547——
Aug 6, 2026Weinstein JudithSee RemarksAWARD2,478——
Aug 6, 2026David GlennChief Financial OfficerAWARD3,334——
Aug 6, 2026Rodriguez PatrickVP Finance and TreasurerAWARD1,503——
Aug 6, 2026BENDHEIM JonathanDirectorAWARD2,716——
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for PAHC.
Shares short
1,142,218
Settlement Sep 15, 2026
Change vs prior
-5.5%
Semi-monthly cycle
Days to cover
4.9
At avg daily volume
Of shares outstanding
≈2.8%
Estimate — not % of float
All PAHC filing & press-release reports (6)